KN060 for treating high blood pressure
Part of Heart & circulation clinical trials.
This trial tests a new medication called KN060 for people with high blood pressure (essential hypertension). It is for those who are not on medication or are on a stable single medication, and whose blood pressure is moderately high but not extremely high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have high blood pressure (essential hypertension) and are either not taking any medication or are on a single medication that hasn't changed in the last 30 days.
- Your blood pressure measured in the office is between 140 and 179 (top number) and your 24-hour average is between 130 and 160.
- You do not have high blood pressure caused by another condition (like kidney disease or sleep apnea).
- You are not taking blood thinners or antiplatelet drugs (like aspirin) and have not had a heart attack or stroke in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.
This study tests a new combination blood pressure medicine (HCP1803-4) for people with essential hypertension. It aims to see if the medicine works better than current options and is safe for long-term use.
This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.
This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.
This early-stage study tests a new medication called IBI3016 to help lower blood pressure in people with mild to moderate hypertension who haven't recently taken blood pressure medications. The goal is to see if this drug is safe and effective.
This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.